Contact AML Alliance
AML Alliance is a subsidiary of Invivoscribe. Invivoscribe is committed to finding biomarkers that will enable targeted therapies that dramatically improve the prognosis for patients diagnosed with AML.
The field of molecular diagnostics is rapidly changing the approach physicians and providers take when a patient is diagnosed with AML. Invivoscribe can offer support for patients diagnosed with AML including providing information sheets to take to your doctor, speaking directly to your doctor, and helping you find a doctor in your area that is aware of the cytogenetic testing that can ensure that you get the right drug, in the right dosage, at the right time.